Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences Group (SLS) Return on Capital Employed: 2013-2023

Historic Return on Capital Employed for SELLAS Life Sciences Group (SLS) over the last 4 years, with Dec 2023 value amounting to 5.75%.

  • SELLAS Life Sciences Group's Return on Capital Employed rose 1103.00% to 5.75% in Q4 2023 from the same period last year, while for Dec 2023 it was 5.75%, marking a year-over-year increase of 1103.00%. This contributed to the annual value of 245.90% for FY2023, which is 25109.00% up from last year.
  • Per SELLAS Life Sciences Group's latest filing, its Return on Capital Employed stood at 5.75% for Q4 2023, which was up 123.39% from -24.60% recorded in Q3 2023.
  • SELLAS Life Sciences Group's Return on Capital Employed's 5-year high stood at 5.75% during Q4 2023, with a 5-year trough of -24.60% in Q3 2023.
  • Moreover, its 3-year median value for Return on Capital Employed was -2.83% (2022), whereas its average is -3.54%.
  • Examining YoY changes over the last 5 years, SELLAS Life Sciences Group's Return on Capital Employed showed a top increase of 1,103bps in 2023 and a maximum decrease of 2,193bps in 2023.
  • Over the past 4 years, SELLAS Life Sciences Group's Return on Capital Employed (Quarterly) stood at -0.85% in 2020, then fell by 8bps to -0.93% in 2021, then plummeted by 434bps to -5.27% in 2022, then skyrocketed by 1,103bps to 5.75% in 2023.
  • Its Return on Capital Employed was 5.75% in Q4 2023, compared to -24.60% in Q3 2023 and -3.55% in Q2 2023.